SCHEDULE: BlackRock Boosts Merit Medical Stake to 14.1%
Beneficial Ownership Report
BlackRock, Inc. has reported an increased beneficial ownership of 14.1% in Merit Medical Systems Inc. common stock, totaling 8,370,301 shares.
Summary
- BlackRock, Inc. has filed an Amendment No. 10 to Schedule 13G, disclosing its beneficial ownership in Merit Medical Systems Inc.
- BlackRock, Inc. beneficially owns an aggregate of 8,370,301 shares of Merit Medical Systems Inc. common stock.
- This ownership represents 14.1% of the class of securities.
- BlackRock, Inc. holds sole voting power over 8,266,306 shares and sole dispositive power over 8,370,301 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- iShares Core S&P Small-Cap ETF, a BlackRock entity, holds more than five percent of the total outstanding common stock of Merit Medical Systems Inc.
- The filing includes an updated Power of Attorney, effective January 21, 2025, which revokes a previous Power of Attorney dated April 30, 2023.
Sentiment
Score: 7
Explanation: The filing indicates a significant institutional stake by BlackRock, which is generally viewed positively as a vote of confidence, though it is a passive ownership disclosure and not an operational update.
Positives
- BlackRock, Inc.'s significant 14.1% stake indicates strong institutional confidence in Merit Medical Systems Inc.
- The investment is stated to be in the ordinary course of business, suggesting a passive, long-term investment strategy rather than an activist one.
Future Outlook
The filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Merit Medical Systems Inc.'s future performance or BlackRock's future investment intentions beyond the passive nature of the holding.
Management Comments
- BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing represents a standard institutional investment disclosure, where a major asset manager like BlackRock, Inc. reports its significant passive stake in a publicly traded company. Such disclosures are common and reflect ongoing portfolio management activities within the investment industry.
Stakeholder Impact
- Shareholders may view BlackRock's substantial and passive stake as a positive signal, potentially increasing confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Date of previous Power of Attorney revoked by the current filing. |
| 01/21/2025 | Effective date of the new Power of Attorney for BlackRock, Inc. |
| 09/30/2025 | Date of event which required the filing of this statement. |
| 10/17/2025 | Date the Schedule 13G was signed by BlackRock, Inc. |
Recommendation
holdBlackRock's significant beneficial ownership of 14.1% in Merit Medical Systems Inc. indicates strong institutional confidence. While this filing is a passive ownership disclosure and does not provide operational or financial performance updates, the substantial stake by a major asset manager like BlackRock suggests a positive long-term view, warranting a 'hold' recommendation for existing investors.
Keywords
BlackRock, Merit Medical Systems, Institutional Ownership, Schedule 13G, Common Stock, Investment, Equity, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.